Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer

Objective: We evaluated whether the blood parameters before prostate biopsy can diagnose prostate cancer (PCa) and clinically significant PCa (Gleason score [GS] ≥7) in our hospital. Methods: This study included patients with increased prostate-specific antigen (PSA) up to 20 ng/mL. The associations...

Full description

Saved in:
Bibliographic Details
Main Authors: Sat Prasad Nepal, Takehiko Nakasato, Takashi Fukagai, Yoshio Ogawa, Yoshihiro Nakagami, Takeshi Shichijo, Jun Morita, Yoshiko Maeda, Kazuhiko Oshinomi, Tsutomu Unoki, Tetsuo Noguchi, Tatsuki Inoue, Ryosuke Kato, Satoshi Amano, Moyuru Mizunuma, Masahiro Kurokawa, Yoshiki Tsunokawa, Sou Yasuda
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Asian Journal of Urology
Subjects:
Blood parameter
Gleason score
Neutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio
Prostate cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S221438822200008X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S221438822200008X

Similar Items